Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.
第一作者:
Antonio,Curti
第一单位:
Institute of Hematology, Department of Hematology and Oncological Sciences L. and A. Seràgnoli, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy. antonio.curti2@unibo.it
作者:
医学主题词
抗原, CD(Antigens, CD);细胞分离(Cell Separation);环磷酰胺(Cyclophosphamide);流式细胞术(Flow Cytometry);移植物白血病反应(Graft vs Leukemia Effect);造血干细胞移植(Hematopoietic Stem Cell Transplantation);组织相容性试验(Histocompatibility Testing);人类(Humans);免疫表型分型(Immunophenotyping);免疫抑制剂(Immunosuppressive Agents);免疫疗法, 过继(Immunotherapy, Adoptive);白细胞介素2(Interleukin-2);杀伤细胞, 天然(Killer Cells, Natural);白细胞去除术(Leukapheresis);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);男(雄)性(Male);中年人(Middle Aged);受体, KIR(Receptors, KIR);复发(Recurrence);缓解诱导(Remission Induction);危险因素(Risk Factors);移植, 同种(Transplantation, Homologous);阿糖腺苷(Vidarabine)
DOI
10.1182/blood-2011-01-329508
PMID
21791425
发布时间
2021-02-06
- 浏览38
Blood
3273-9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



